376
Participants
Start Date
September 20, 2011
Primary Completion Date
June 18, 2012
Study Completion Date
June 18, 2012
COV795
COV795 is a multilayer extended-release tablet for oral administration of oxycodone hydrochloride (15 mg) and acetaminophen (650 mg)
Allegheny Pain Management, Altoona
The Center for Clinical Research, Winston-Salem
Peters Medical Research, High Point
Drug Studies America, Marietta
Better Health Clinical Research, Newnan
Accord Clinical Research, LLC, Port Orange
Avail Clinical Research, DeLand
Compass Research East, LLC, Oviedo
Clinical Neuroscience Solutions, Inc., Orlando
Compass Research, LLC, Orlando
Eastern Research, Hialeah
Scientific Clinical Research, Inc., North Miami
Gold Coast Research LLC, Plantation
Orthopedic Research Institute, Boynton Beach
Stedman Clinical Trials, Tampa
Sarasota Pain Medicine Research, LLC, Sarasota
Community Research, Crestview Hills
Commonwealth Biomedical Research, LLC, Madisonville
Hightop Medical Research Center/Hilltop Physicians Inc., Cincinnati
New Horizons Clinical Research, Cincinnati
Community Research, Cincinnati
MediSphere Medical Research Center, LLC, Evansville
QUEST Research Institute, Bingham Farms
Chicago Anesthesia Pain Specialists, Chicago
Sundance Clinical Research, St Louis
International Clinical Research Institute, Leawood
Quality Clinical Research, Omaha
KRK Medical Research, Dallas
FutureSearch Trials, Austin
Austin Diagnostic Clinic, Austin
Optimum Clinical Research, Inc., Salt Lake City
Genova Clinical Research, Tucson
Associated Pharmaceutical Research Center, Inc., Buena Park
Skyline Research, Inc., Long Beach
Catalina Research Institute, LLC, Chino
Triwest Research Associates, La Mesa
Synergy Escondido Clinical Research, Escondido
Advanced Clinical Research Institute, Anaheim
Orange County Research Institute, Anaheim
United Clinical Research Center, Inc., Anaheim
Convergys Clinical Research, Inc., Fresno
Premier Research, Trenton
Lead Sponsor
Mallinckrodt
INDUSTRY